ArticleIrish journal of medical science2026
Comparative radiologic characteristics of isotretinoin-induced sacroiliitis and axial spondyloarthritis.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Sacroiliitis and Long-Term Effects on Bones and Joints Following Isotretinoin Use.International journal of rheumatic diseases · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSacroiliitis is a major cause of inflammatory low back pain in young adults and a key feature of spondyloarthritis (SpA), but it may also occur with infection, pregnancy, or drug exposure. Isotretinoin, widely used for severe acne, can rarely induce sacroiliitis.
aimThis study aimed to compare the MRI characteristics of isotretinoin-induced sacroiliitis with those of axial spondyloarthritis (axSpA).
methodsThe study population consisted of 68 patients, comprising 28 with isotretinoin-induced sacroiliitis (median age 24 years; 5 males) and 40 with axSpA (median age 30 years; 26 males). MRI scans were assessed for active inflammatory lesions (bone marrow edema, synovitis, capsulitis, enthesitis) and early structural lesions (erosion, fat metaplasia). SPARCC scoring was performed using the standardized 0-72 system. Ankylosis and sclerosis were not included as it was absent in both groups. Group comparisons were conducted using the Mann-Whitney U test, chi-square test, or Fisher's exact test.
resultsWhile isotretinoin-induced sacroiliitis showed a purely inflammatory pattern without structural lesions, patients with axSpA exhibited both active inflammatory and structural lesions. Erosions and fat metaplasia were observed exclusively in axSpA patients (p < 0.001). Bilateral and symmetric involvement, as well as higher SPARCC scores, were significantly more frequent in axSpA (p < 0.05).
conclusionIsotretinoin-induced and axSpA sacroiliitis exhibit distinct MRI characteristics. Erosions and fat metaplasia are specific markers of axSpA, whereas isotretinoin-induced sacroiliitis represents a reversible, non-destructive inflammatory process. The present results may assist clinicians and radiologists in distinguishing between these two conditions in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.